Atlas Trials

Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)

Clinical trial NCT04678453 · TERMINATED

Trial details

NCT number
NCT04678453
Sponsor
NKGen Biotech, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer DiseaseNeuro-Degenerative Disease
Start date
2021-01-06
Primary completion
2023-08-16
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.